IBM Health Innovation

20
Neurostatus Systems GmbH Roland John (COO) and Beat Gersbach (CTO) IBM Health Innovation 2013

description

IBM Health Innovation Forum 2013, Rueschlikon, CH

Transcript of IBM Health Innovation

Page 1: IBM Health Innovation

Neurostatus Systems GmbHRoland John (COO) and Beat Gersbach (CTO)

IBM Health Innovation 2013

Page 2: IBM Health Innovation

Table of contents

− Neurostatus e-Scoring

− Business Challenge

− Solution

− Summary, Q&A

05-NOV-2013 Neurostatus Systems GmbH 2

Page 3: IBM Health Innovation

Neurostatus e-Scoring

− Electronic Data Capturing

(EDC)

− Clinical Trials

− EDSS scale: Gold Standard to

assess the overall status of

patients in Multiple Sclerosis

– Expanded Disability Status Scale

05-NOV-2013 Neurostatus Systems GmbH 3

Page 4: IBM Health Innovation

Background

05-NOV-2013 Neurostatus Systems GmbH 4

Full Neurological Examination:

120 Sub-Scores

8 Functional System Scores

1 EDSS Step

Page 5: IBM Health Innovation

Process until now1. Analog data capturing (paper)2. FS Score and EDSS Step calculation (brainwork)3. Data Transfer to Sponsor (Fax)4. Digitizing of data (partially)5. Quality control (manual calculation)6. Queries to EDSS rater

− too many steps− too much time, noise and ressources

� bad data quality

05-NOV-2013 Neurostatus Systems GmbH 5

Page 6: IBM Health Innovation

Direct and fast !

05-NOV-2013 Neurostatus Systems GmbH 6

Bring the solution to the end user:

−Electronic data capturing

−On site quality control (e-Scoring Algorithm)

−Instant feedback and data clarification

� Mobile solution

Page 7: IBM Health Innovation

Improved data quality

05-NOV-2013 Neurostatus Systems GmbH 7

Page 8: IBM Health Innovation

Numbers

05-NOV-2013 Neurostatus Systems GmbH 8

Page 9: IBM Health Innovation

System Components

05-NOV-2013 Neurostatus Systems GmbH 9

Web Application NS Server iPad

Neurostatus e-Scoring

Page 10: IBM Health Innovation

Business Model

05-NOV-2013 Neurostatus Systems GmbH 10

Neurologists / Hospital (End User)

Pharma Companies / Clinical Trials (Customers)

Neurostatus SystemsSystem development and operations

UHBS, BaselProf. Kappos, Scientific background

Page 11: IBM Health Innovation

350 Sites in 30 Countries

05-NOV-2013 Neurostatus Systems GmbH 11

Page 12: IBM Health Innovation

Business Challenges

− Enterprise Level, but worldwide distributed end users

05-NOV-2013 Neurostatus Systems GmbH 12

Page 13: IBM Health Innovation

Regulatory Requirements

− Qualified and Validated infrastructure according to FDA/EMA regulatory requirements

− Validated = Controlled and documented installation according guidelines

05-NOV-2013 Neurostatus Systems GmbH 13

AuthenticityAuthenticity IntegrityIntegrity TraceabilityTraceability

Page 14: IBM Health Innovation

− Controlled Access / Profiling

− Secure Data Transfer

− Remote Control

Integrated Neurostatus Infrastructure

05-NOV-2013 Neurostatus Systems GmbH 14

Infrastructure Requirements

Page 15: IBM Health Innovation

Solution

05-NOV-2013 Neurostatus Systems GmbH 15

Page 16: IBM Health Innovation

Main Infrastructure Components− Dedicated App Store (Apple Enterprise Store)

– To be (almost) independent on Apple guidelines

− Mobile Data Communication (Swisscom)– Secure data transfer; M2M with VPN / APN

− Qualified Infrastructure (Symotech AG)– Regulatory Compliance

− Mobile Device Management (IBM Endpoint Manager)– Sophisticated Profiling, Remote Control

05-NOV-2013 Neurostatus Systems GmbH 16

Page 17: IBM Health Innovation

Why IBM Endpoint Manager ?

− Multi Platform

– Scalability, Diversification

− Fixlets

– Optimization, Operations and Reporting

− Supports Apple Profiling

– Controls and Restrictions

05-NOV-2013 Neurostatus Systems GmbH 17

Page 18: IBM Health Innovation

Operations

− Before delivery

– Staging and Profiling

− After delivery

– Establishing Connectivity remotely

– Support and Maintenance

05-NOV-2013 Neurostatus Systems GmbH 18

Page 19: IBM Health Innovation

Summary

− Challenging

− Regulatory compliant but flexible Solution

− Expected growth

− Pros and Cons with Apple

− Close Collaboration with IBM Engineering

05-NOV-2013 Neurostatus Systems GmbH 19

Page 20: IBM Health Innovation

Thank you!

05-NOV-2013 Neurostatus Systems GmbH 20